看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 3.6x - 4.0x | 3.8x |
| Historical Pb Multiple | 2.6x - 5.1x | 3.3x |
| Fair Value | ₩2,752 - ₩3,042 | ₩2,897 |
| Upside | 11.4% - 23.1% | 17.3% |
| Benchmarks | - | Full Ticker |
| Chemtros Co., Ltd. | - | KOSDAQ:A220260 |
| Jeonjinbio Co., Ltd. | - | KOSDAQ:A110020 |
| NANOCMS Co.,Ltd | - | KOSDAQ:A247660 |
| KNW Co., Ltd. | - | KOSDAQ:A105330 |
| Nousbo Co., Ltd. | - | KOSDAQ:A332290 |
| NANOBRICK Co., Ltd. | - | KOSDAQ:A286750 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| A220260 | A110020 | A247660 | A105330 | A332290 | A286750 | |||
| KOSDAQ:A220260 | KOSDAQ:A110020 | KOSDAQ:A247660 | KOSDAQ:A105330 | KOSDAQ:A332290 | KOSDAQ:A286750 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -12.6% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 23.1% | NM- | NM- | -25.5% | NM- | NM- | ||
| Latest Twelve Months | 83.5% | 167.5% | -118.2% | 67.7% | 150.6% | 103.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 6.0% | -45.2% | -45.9% | 0.7% | -4.7% | -45.1% | ||
| Prior Fiscal Year | 6.7% | -41.1% | 2.8% | 2.2% | -6.0% | -33.6% | ||
| Latest Fiscal Year | 5.9% | 22.6% | -90.2% | 4.4% | -7.3% | -97.3% | ||
| Latest Twelve Months | 8.0% | 22.6% | -136.2% | 4.4% | -1.6% | -26.1% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 5.5% | -39.9% | -14.9% | 2.0% | -13.4% | -20.5% | ||
| Prior Fiscal Year | 5.5% | -81.9% | 0.7% | 2.0% | -23.3% | -63.3% | ||
| Latest Twelve Months | 6.2% | 36.4% | -26.2% | 2.7% | 12.3% | 1.8% | ||
| Next Fiscal Year | 4.3% | -43.5% | #NUM! | -3.4% | 8.4% | 45.0% | ||
| Two Fiscal Years Forward | 4.1% | -68.1% | -16.7% | -3.5% | 11.4% | 58.4% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 2.4x | 1.1x | 5.1x | 0.8x | 0.4x | 10.1x | ||
| Price / LTM EPS | 30.2x | 5.1x | -3.8x | 17.2x | 11.5x | 224.3x | ||
| Price / Book | 1.8x | 1.2x | 1.1x | 0.5x | 1.3x | 3.3x | ||
| Price / Fwd Book | 1.7x | 1.9x | 0.9x | 0.5x | 1.2x | 2.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.5x | 1.2x | 1.8x | |||||
| Historical P/B Ratio | 2.6x | 3.3x | 5.1x | |||||
| Selected P/B Multiple | 3.6x | 3.8x | 4.0x | |||||
| (x) Book Value | 16,345 | 16,345 | 16,345 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A220260 | A110020 | A247660 | A105330 | A332290 | A286750 | |
| Value of Common Equity | 115,927 | 21,922 | 25,286 | 58,879 | 34,748 | 53,136 | |
| (/) Shares Outstanding | 26.6 | 9.1 | 4.3 | 15.9 | 32.9 | 21.5 | |
| Implied Stock Price | 4,365.00 | 2,420.00 | 5,920.00 | 3,710.00 | 1,056.00 | 2,470.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4,365.00 | 2,420.00 | 5,920.00 | 3,710.00 | 1,056.00 | 2,470.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |